Rehmann Capital Advisory Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Rehmann Capital Advisory Group’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$87.5K	Hold	882	–	–	0.01%	479
2019 Q2	$87.5K	Sell	882 -16	-2%	-$1.53K	0.01%	650
2019 Q1	$99K	Sell	898 -52	-5%	-$5.43K	0.01%	591
2018 Q4	$87.4K	Sell	950 -16	-2%	-$1.62K	0.01%	436
2018 Q3	$106K	Hold	966	–	–	0.01%	571
2018 Q2	$90.2K	Sell	966 -15	-2%	-$1.29K	0.01%	582
2018 Q1	$81K	Sell	981 -2,038	-68%	-$181K	0.01%	607
2017 Q4	$275K	Buy	+3,019	New	+$251K	0.05%	298

Other funds holding PRAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Rehmann Capital Advisory Group's PRAH Position: Q3 2019 in Review

Rehmann Capital Advisory Group held its PRA Health Sciences, Inc. (PRAH) position steady in Q3 2019 at 882 shares worth $87.5K. The position accounts for 0.01% of the portfolio, ranked #479.

Rehmann Capital Advisory Group first reported a position in PRAH in Q4 2017 and has held it in 8 quarters since. The position peaked at $275K in Q4 2017. 329 funds tracked by Wall St. Rank hold PRAH as of Q3 2019.

Rehmann Capital Advisory Group held 882 shares of PRA Health Sciences, Inc. worth $87.5K as of Q3 2019.
Rehmann Capital Advisory Group left its PRA Health Sciences, Inc. share count unchanged in Q3 2019.
PRA Health Sciences, Inc. made up 0.01% of Rehmann Capital Advisory Group's portfolio in Q3 2019, its #479 holding.
Rehmann Capital Advisory Group first reported a position in PRA Health Sciences, Inc. in Q4 2017 and has held it in 8 quarters since.
Rehmann Capital Advisory Group's PRA Health Sciences, Inc. position peaked at $275K in Q4 2017.
329 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2019.

Based on Rehmann Capital Advisory Group's 13F filing for Q3 2019, filed 2 Jan 2020.